NZVRSU

EUQG

Granocyte 13 Million Iu, And 34 Million Iu

Di: Henry

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe

GRANOCYTE 34 million IU/mL, powder and solvent for solution

Granocyte 34 1 St mit dem E-Rezept kaufen - Shop Apotheke

• PBPC mobilisation after chemotherapy. GRANOCYTE 34 million IU/mL can be used in patients with body surface area up to 1.8 m 2. For PBPC mobilisation with GRANOCYTE alone, the GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe – Lenograstim Lenograstim – Colony stimulating GRANOCYTE ® 34 _Lenograstim _ Powder and solvent for solution for injection or infusion in pre-filled syringes NAME OF THE MEDICINAL PRODUCT GRANOCYTE 34 million IU/mL,

GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe * Therefore, GRANOCYTE 13 million IU/mL and GRANOCYTE 34 million IU/ml should be used in children, in particular with favorable long term prognosis, only after careful weighting of short GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion – Patient Information Leaflet (PIL) by Chugai Pharma UK Limited

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe Pharmacy Only: Prescription GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe – Patient Information Leaflet (PIL) by Chugai Pharma UK

Granocyte 34 MIU/vial SC Injection (rHuG-CSF) 13.4 million International Units (equivalent to 105 micrograms) per ml after reconstitutionGranocyte 34 MIU/vial SC Injection

GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe – Summary of Product Characteristics (SmPC) by Chugai Pharma UK Limited

Granocyte SC Injection 34 million unit vial

  • Granocyte 13 million IU, and 34 million IU
  • Granocyte SC Injection 34 million unit vial
  • Granocyte 34million unit powder and solvent for solution

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe • PBPC mobilisation after chemotherapy. GRANOCYTE 13 million IU/mL can be used in patients with body surface area up to 0.7 m 2. For PBPC mobilisation with GRANOCYTE alone, the

GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion – Summary of Product Characteristics (SmPC) by Chugai Pharma UK Limited • The recommended pre filled syringe dose of GRANOCYTE is 150 µg (19.2 MIU) per m² per day, therapeutically equivalent to 5 µg (0.64 MIU) per kg per day for: – peripheral stem cells or bone

Ürünler | Eczacıbaşı İlaç Pazarlama

Uses Granocyte-34 (rHuG-CSF) 13.4 million International Units (equivalent to 105 micrograms) per ml after reconstitution Granocyte-34 (rHuG-CSF) cells or bone Uses Granocyte 33.6 million International GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe *

  • Lenograstim: Uses, Interactions, Mechanism of Action
  • Granocyte-34: Uses, Dosage, Side Effects, Food Interaction & FAQ
  • GRANOCYTE 13 13 million IU/ML Pdr+Solv for soln for
  • GRANOCYTE 34 34 million IU/ML Pdr+Solv for soln for

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe Pharmacy Only: Prescription GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe – Summary of Product Characteristics (SmPC) by

Document history – Granocyte 13 million IU, and 34 million IU – Summary of Product Characteristics (SmPC) by Chugai Pharma UK Limited

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion 2 Therefore , GRANOCYTE 13 mil IU/mL and GRANOCYTE thirty four million IU/ml should be utilized in children, especially with advantageous long term diagnosis, only after careful

PBPC mobilisation after chemotherapy. Lenograstim 13 million IU/mL can be used in patients with body surface area up to 0.7 m2. Lenograstim 34 million IU/mL can be used in patients with Document history – Granocyte 13 million IU, and 34 million IU – Patient Information Leaflet (PIL) by Chugai Pharma UK Limited

GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe * Lenograstim is also indicated to accelerate the engraftment of these cells after their reinfusion. GRANOCYTE is also indicated for the treatment of severe chronic neutropenia SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion 2

Granocyte SC Injection 34 million unit vialLenograstim is the glycosylated recombinant form of human granulocyte colony stimulating factor. Lenograstim accelerates neutrophil recovery The safety and efficacy of GRANOCYTE in children aged less than 2 years have not been established. GRANOCYTE 13 million IU/mL may be the more appropriate dosage for GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion in a pre-filled syringe. GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion.